Home › Urothelial (Transitional Cell) Carcinoma › Texas › Irving
Urothelial (Transitional Cell) Carcinoma clinical trials in Irving, TX
3 studies for Urothelial (Transitional Cell) Carcinoma are looking for participants at sites in and around Irving (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
RecruitingPhase 1
- Exelixis Clinical Site #73, Irving
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
RecruitingPhase 1/2
- US Oncology Investigational Product Center (IPC), Irving
- US Oncology Investigational Products Center (IPC), Irving
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
RecruitingPhase 1
- NEXT Oncology Dallas, Irving
Urothelial (Transitional Cell) Carcinoma trials in other cities
- Nashville, TN23 studies
- New York City, NY22 studies
- Dallas, TX18 studies
- Edison, NJ18 studies
- Houston, TX18 studies
- Los Angeles, CA17 studies
- Queens, NY15 studies
- Chicago, IL14 studies
- Arlington, VA12 studies
- San Antonio, TX11 studies
- Boston, MA11 studies
- Austin, TX10 studies
Other studies in Irving
- Non-Small Cell Lung Cancer22 studies
- Cancer (all types)15 studies
- Colorectal Cancer13 studies
- Metastatic Cancer11 studies
- Pancreatic Cancer7 studies
- Stomach Cancer7 studies
- Head and Neck Squamous Cell Carcinoma6 studies
- Breast Cancer6 studies
- Small Cell Lung Cancer6 studies
- Lung Cancer6 studies
- Ovarian Cancer5 studies
- Endometrial Cancer4 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.